Skip to content
pindobind

Structure via PubChem · Public domain (PubChem)

EntityQ7195029· pop 5· linked from 1,366 articles

Pindobind is a compound developed by researchers associated with Stanford University, identified as a central nervous system depressant, which generated a response in animals reducing offensive actions such as chasing, while also notably reducing tendencies of the test animal to evade when stimulated to do so. It acts as an irreversible beta blocker and irreversible 5-HT1A receptor antagonist.

Chemical data

Formula
C23H34BrN3O3
Molecular weight
480.4 g/mol
IUPAC name
2-bromo-N-[4-[2-[[2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino]propan-2-yl]-1-methylcyclohexyl]acetamide
SMILES
CC1(CCC(CC1)C(C)(C)NCC(COC2=CC=CC3=C2C=CN3)O)NC(=O)CBr
InChIKey
XSAGAZCYTLNCEN-UHFFFAOYSA-N
XLogP
3.4
Polar surface area
86.4 Ų
H-bond donors
4
H-bond acceptors
4
Formal charge
0

via PubChem

Drug data · ChEMBL

Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Has part
bromine
Mass
479.178354
Has use
medication
Show 2 more facts
chemical formula
C₂₃H₃₄BrN₃O₃
canonical SMILES
CC1(CCC(CC1)C(C)(C)NCC(COC2=CC=CC3=C2C=CN3)O)NC(=O)CBr
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

{{Chembox | ImageFile = Pindobind.svg | ImageSize = 200px | IUPACName = 2-Bromo-N-[4-(2-{[2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino}-2-propanyl)-1-methylcyclohexyl]acetamide | OtherNames = |Section1= |Section2= |Section3= }}

Pindobind is a compound developed by researchers associated with Stanford University, identified as a central nervous system depressant, which generated a response in animals reducing offensive actions such as chasing, while also notably reducing tendencies of the test animal to evade when stimulated to do so. It acts as an irreversible beta blocker and irreversible 5-HT1A receptor antagonist.

Excerpted from Wikipedia’s “pindobind” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0